Position in HLN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$939,158
+$607,090 QoQ
Shares Held
93,822
+193.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
147,055 | $10,567,372 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,271 | $7,732,455 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
190,145 | $6,592,327 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
136,725 | $5,609,826 | |
| 5 | VTRS |
Viatris Inc
|
331,130 | $5,258,344 | |
| 6 | PRGO |
PERRIGO Co plc
|
346,586 | $3,601,028 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
411,346 | $3,257,860 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
34,505 | $2,856,323 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $939,158 | 93,822 | Shares | Sole | 2026-04-27 | |
| 2025-06-30 | $332,068 | 32,022 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $744,728 | 72,374 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $600,436 | 56,752 | Shares | Sole | 2024-11-15 | |
| 2024-03-31 | $922,260 | 108,629 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $106,380 | 12,926 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $92,783 | 11,072 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $507,651 | 62,365 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,378,232 | 172,279 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||